Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03556839
Title Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the Cervix (BEATcc)
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Grupo Espanol de Investigacion en Cancer de Ovario

cervical adenosquamous carcinoma

cervical squamous cell carcinoma

cervical adenocarcinoma


Atezolizumab + Bevacizumab + Cisplatin + Paclitaxel

Atezolizumab + Bevacizumab + Carboplatin + Paclitaxel

Bevacizumab + Carboplatin + Paclitaxel

Bevacizumab + Cisplatin + Paclitaxel

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU

No variant requirements are available.